Carbohydrates for life, health and diseases
What molecules determine human ABO blood groups? What do influenza viruses grab when they infect a human? What define the serotypes of bacterial species? What are the most diverse protein post-translational modifications? The answer to all of these questions is “carbohydrates.”
Indeed, carbohydrates are indispensable biomolecules and components that are essential for life. They are key recognition components of many biological and pathological events. Synthesizing glycans and understanding the roles of carbohydrates used to be daunting tasks but, thanks to recent progress, have become easier.
The exciting talks in our symposium at Discover BMB, the annual meeting of the American Society for Biochemistry and Molecular Biology, which will be held in March in Seattle, will present recent advances made on several fronts: glycan synthesis, tools developed, chemical biology, and the roles and the applications of carbohydrates in health and diseases.
The topics include human and bacterial glycans, biocatalysis, chemoenzymatic synthesis, glycomics, glycoproteomics, anti-glycan antibodies and the roles and applications in learning, memory and treatment of adult diseases.
We aim to engage aficionados as well as those interested in learning more about how to implement these approaches in their own research.
Keywords: Biocatalysis, carbohydrates, glycans, glycoscience, synthesis, recognition.
Who should attend: Anyone interested in the recent advances in the synthesis, roles and applications of glycans and glycoconjugates.
Theme song: “Watermelon Sugar” by Harry Styles.
This session is powered by a sugar rush.
Speakers
Synthesis of glycans for exploring their role in health and disease
Xi Chen (chair), University of California, Davis
Catherine L. Grimes, University of Delaware
Rita Gerardy–Schahn, Hannover Medical School
Steven D. Townsend, Vanderbilt University
Jerry Troutman, University of North Carolina at Charlotte
Chemical glycobiology and tools for glycoscience
Catherine Grimes (chair), University of Delaware
Mireille Kamariza, Harvard University
Jeff Gildersleeve, National Cancer Institute
Lingjun Li, University of Wisconsin
Tania Lupoli, New York University
Carbohydrate biocatalysts and glycan-binding probes/materials
Catherine Grimes (chair), University of Delaware
Xi Chen, University of California, Davis
Barbara Imperiali, Massachuetts Institute of Technology
Kelley Moremen, University of Georgia
Vered Padler–Karavani, Tel Aviv University
The complete list
Learn about all 11 symposia planned for Discover BMB 2023:- Protein Machines and Disorder
- Regulation of RNA
- Organelles, Mechanisms and Phase Properties of Cellular Quality Control
- Lipid Dynamics and Signals in Membrane and Protein Structure
- Frontiers in Carbohydrate Synthesis and Recognition
- Bias In, Bias Out in Data Science
- Cell Signaling — New Tools and Emerging Concepts
- Education and Professional Development
- Biochemistry of Elemental Cycling
- Advances in Organismal and Cellular Metabolism
- Artificial Intelligence and Machine Learning in Structural Biology, Drug Design and Systems Biology
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Guiding grocery carts to shape healthy habits
Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.
Quantifying how proteins in microbe and host interact
“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.
Leading the charge for gender equity
Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.
CRISPR gene editing: Moving closer to home
With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.
Finding a missing piece for neurodegenerative disease research
Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.
From the journals: JLR
Enzymes as a therapeutic target for liver disease. Role of AMPK in chronic liver disease Zebrafish as a model for retinal dysfunction. Read about the recent JLR papers on these topics.